Natural-Knee(R) and Natural Knee(R)Ii W/Csti(Tm)
Prosthesis, knee, patello/femorotibial, unconstrained, uncemented, porous, coated, polymer/metal/polymer. PMA P940002, from Sulzermedica (Austin, TX). Product code MBD, class 3.
As of Nov 18, 2026, P940002 is an FDA PMA held by Sulzermedica, approved on Mar 21, 1997 after 1,162 days, with no recalls tied to it in FDA's recall database.
- Review time: 1,162 days
- Supplements: 4
- Recalls: 0
- Cited as a predicate by: 2 devices
What FDA approved
FDA's approval order statementApproval for the natural-knee(r) and natural knee(r) ii with csti(tm). These devices are indicated for uncemented use in skeletally mature individuals with intact medial and lateral collateral ligaments undergoing primary surgery for rehabilitating knees damaged as a result fo noninflammatory degenerative joint disease (nidjd) or inflammatory joint disease (ijd)
Cited as a predicate
2 later 510(k) summaries name this device as a predicate- Gender Solutions Natural-Knee Flex SystemK070214 · Zimmer, Inc. · Mar 16, 2007
- Natural-Knee Ii Unicompartmental Knee SystemK033810 · Centerpulse Orthopedics, Inc. · Mar 5, 2004
Supplements
4 supplements to this PMA| Aug 1, 2001 | S005Process Change - Manufacturer/Sterilizer/Packager/Supplier | Special (Immediate Track) |
| Apr 18, 2000 | S003Process Change - Manufacturer/Sterilizer/Packager/Supplier | Special (Immediate Track) |
| Oct 16, 1997 | S002Location Change - Manufacturer/Sterilizer/Packager/Supplier | Normal 180 Day Track |
| Apr 30, 1997 | S001Labeling Change - Indications/instructions/shelf life/tradename | Real-Time Process |
Record
- Document
- Approval order (PDF) ↗
- Type
- Original PMA
- Received
- Jan 14, 1994
- Review panel
- Orthopedic
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files